Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil

Pediatric Transplantation

Volumn 9, Issue 2, 2005, Pages 178-182

  Ferraris, Jorge R ^a,b,d   Ghezzi, Lidia F R ^a   Vallejo, Graciela ^b   Piantanida, Juan J ^b   Araujo, Jose L ^c   Sojo, Ernesto T ^b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Unidad de Nefrologia Pediatrica   (Argentina)

^c Scientific and Technical Section   (Argentina)

^d NONE   (Argentina)

Author keywords

Acute rejection; Allograft function; Cyclosporine; Growth; Mycophenolate mofetil; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

ADOLESCENT; ARTICLE; CANCER; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PREPUBERTY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 16444362273     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00272.x     Document Type: Article

References (15)

1. TEJANI A, SULLIVAN EK. The impact of acute rejection on chronic rejection: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000: 4: 107-111.
2. MORRIS RE, HOYT EG, MURPHY MP, EUGUI EM, ALLISON AC. Mycophenolic acid morpholinoethyl ester (RS-6134) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T and B cell purine synthesis. Transplant Proc 1990: 22: 1659-1662.
3. SOLLINGER HW, US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995: 60: 225-232.
4. European Mycophenolate Mofetil Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321-1325.
5. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029-1037.
6. MEIER-KRIESCHE HU, STEFFEN BJ, HOCHBERG AM, et al. Mycophenolate mofetil versus azathioprine therapy is associated with significant protection against long-term renal allograft function deterioration. Transplantation 2003: 75: 1341-1346.
7. OJO AO, MEIER-KRIESCHE HU, HANSON JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000: 69: 2405-2409.
8. JUNGRAITHMAYR T, STASKEWITZ A, KIRSTE G, et al. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Transplantation 2003: 75: 454-461.
9. FERRARIS JR, TAMBUTTI ML, REDAL MA, BUSTOS D, RAMIREZ JA, PRIGOSHIN N. Conversion from azathioprina to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection. Transplantation 2000: 70: 297-301.
10. KASISKE BL, ANDANY MA, HERNANDEZ D, et al. Comparing methods of monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis 2001: 38: 1065-1073.
11. FERRARIS JR, RAMIREZ JA, Ruiz S, et al. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation. Pediatr Nephrol 2002: 17: 809-814.
12. SOROF JM, GOLDSTEIN SL, BREWER ED, STEIGER HM, PORTMAN RJ. Use of anti-hypertensive medications and post-transplant renal allograft function in children. Pediatr Transplantation 2000: 4: 21-27.
13. CURTIS JJ, LUKE RG, DUBOVSKY E, DIETHELM AG, WHELCHEL JD, JONES P. Cyclosporine in therapeutic doses increases renal allograft vascular resistance. Lancet 1986: 2: 477-479.
14. FALKENHAIN ME, COSIO FG, SEDMARK DO. Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation 1996: 62: 364-370.
15. KNOLL GA, MCDONALD I, KHAN A, VAN WALRAVEN C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003: 14: 2381-2386.